TY - JOUR
T1 - Validity of the Arabic International Physical Activity Questionnaire to Measure Moderate-to-Vigorous Physical Activity in People with Diabetes
AU - Al Ozairi, Ebaa
AU - Alsaraf, Husain
AU - Al-Ozairi, Abdullah
AU - Hamdan, Yasmine
AU - Al Esmaeel, Batool Camille
AU - Alsaeed, Dalal
AU - Abdalla, Mohamed
AU - Gray, Stuart R.
N1 - Publisher Copyright:
© 2024 Al Ozairi et al.
PY - 2024
Y1 - 2024
N2 - Purpose: The aim of this cross-sectional study was to compare the Arabic version of International Physical Activity Questionnaire (IPAQ) measured moderate-to-vigorous physical activity (MVPA) with accelerometer-measured MVPA in people with diabetes. Methods: From 2020 to 2022 physical activity was measured people ≥18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations. Results: We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = −0.011 (−0.038, 0.017), p = 0.444) and excluding (rho = −0.001 (−0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(−85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(−60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p < 0.001) and excluding (rho = 0.34 (0.27, 0.41), p < 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI −61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI −34.1 to 42.0) min/day higher, when excluding walking. Conclusion: In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.
AB - Purpose: The aim of this cross-sectional study was to compare the Arabic version of International Physical Activity Questionnaire (IPAQ) measured moderate-to-vigorous physical activity (MVPA) with accelerometer-measured MVPA in people with diabetes. Methods: From 2020 to 2022 physical activity was measured people ≥18 years with type 1 or type 2 diabetes in Kuwait. Self-reported MVPA was measured over 7 days with the Arabic version of the IPAQ. During the same 7-day period wrist worn accelerometers were used to objectively measure MVPA. IPAQ MVPA was calculated both including and excluding walking physical activity. MVPA measures were compared by limits of agreement approach, Pearson correlations and concordance correlations. Results: We recruited 240 participants with type 1 diabetes and 343 participants with type 2 diabetes for the study. In people with type 1 diabetes, there were no concordance correlations between IPAQ MVPA, both including (rho = −0.011 (−0.038, 0.017), p = 0.444) and excluding (rho = −0.001 (−0.067, 0.065), p = 0.978) walking physical activity. MVPA measured by IPAQ was 43.3(−85.6, 172.2) min/day higher than accelerometer-measured MVPA, when including walking, and 8.88(−60.4, 78.2) min/day higher, when excluding walking. In people with type 2 diabetes, there were significant positive concordance correlations between IPAQ MVPA, both including (rho = 0.038 (0.02, 0.06), p < 0.001) and excluding (rho = 0.34 (0.27, 0.41), p < 0.001) walking physical activity. MVPA measured by IPAQ was 62.3 (95% CI −61.5 to 186.0) min/day higher than accelerometer-measured MVPA, when including walking, and 4.0 (95% CI −34.1 to 42.0) min/day higher, when excluding walking. Conclusion: In people with type 1 or type 2 diabetes, caution should be exercised when using the Arabic version of the IPAQ to measure MVPA.
KW - Arab
KW - activity
KW - metabolic disease
KW - validation
UR - http://www.scopus.com/inward/record.url?scp=85205238598&partnerID=8YFLogxK
U2 - 10.2147/DMSO.S474202
DO - 10.2147/DMSO.S474202
M3 - Article
AN - SCOPUS:85205238598
VL - 17
SP - 3491
EP - 3498
JO - Diabetes, Metabolic Syndrome and Obesity
JF - Diabetes, Metabolic Syndrome and Obesity
ER -